{"id":25981297,"date":"2025-12-19T07:05:54","date_gmt":"2025-12-19T07:05:54","guid":{"rendered":"https:\/\/www.nutagen.com\/co-je-treba-udelat-nez-bude-starnuti-lecitelne\/"},"modified":"2025-12-19T07:05:54","modified_gmt":"2025-12-19T07:05:54","slug":"co-je-treba-udelat-nez-bude-starnuti-lecitelne","status":"publish","type":"post","link":"https:\/\/nutagen.com\/cs\/co-je-treba-udelat-nez-bude-starnuti-lecitelne\/","title":{"rendered":"Co je t\u0159eba ud\u011blat, ne\u017e bude st\u00e1rnut\u00ed l\u00e9\u010diteln\u00e9"},"content":{"rendered":"

Rozs\u00e1hl\u00fd pr\u016fzkum poukazuje na v\u00fdzvy, kter\u00e9 je t\u0159eba p\u0159ekonat, aby se v\u00fdzkum dlouhov\u011bkosti posunul vp\u0159ed<\/strong><\/p>\n

Touha prodlou\u017eit lidsk\u00fd \u017eivot<\/a> a podpo\u0159it zdrav\u011bj\u0161\u00ed st\u00e1rnut\u00ed se z science fiction sc\u00e9n\u00e1\u0159e stala hmatateln\u00fdm v\u011bdeck\u00fdm c\u00edlem. V posledn\u00edch letech pos\u00edlily pokroky ve v\u00fdzkumu dlouhov\u011bkosti optimismus, \u017ee st\u00e1rnut\u00ed lze v pr\u016fb\u011bhu na\u0161eho \u017eivota \u00fa\u010dinn\u011b bojovat. Na cest\u011b k tomuto ambici\u00f3zn\u00edmu c\u00edli v\u0161ak st\u00e1le existuj\u00ed zna\u010dn\u00e9 p\u0159ek\u00e1\u017eky. Na z\u00e1klad\u011b poznatk\u016f, kter\u00e9 z\u00edskalo konsorcium Longevity Biotech Fellowship Bottleneck<\/em><\/a> Consortium v pr\u016fzkumu mezi 400 odborn\u00edky, uv\u00e1d\u00edme zde p\u011bt kl\u00ed\u010dov\u00fdch komponent, kter\u00e9 jsou nezbytn\u00e9 pro pokrok ve v\u00fdzkumu dlouhov\u011bkosti.<\/p>\n

1. Precizace biomarker\u016f st\u00e1rnut\u00ed<\/h3>\n

P\u0159esn\u00e9 hodnocen\u00ed \u00fa\u010dinnosti opat\u0159en\u00ed proti st\u00e1rnut\u00ed z\u00e1vis\u00ed na spolehliv\u00fdch biomarkerech<\/a> st\u00e1rnut\u00ed. Methylov\u00e1n\u00ed DNA<\/a> se sice \u010dasto pou\u017e\u00edv\u00e1, ale nepokr\u00fdv\u00e1 cel\u00e9 spektrum zm\u011bn souvisej\u00edc\u00edch s v\u011bkem. V\u00fdvoj komplexn\u00edch biomarker\u016f, kter\u00e9 odr\u00e1\u017eej\u00ed r\u016fzn\u00e9 aspekty st\u00e1rnut\u00ed nez\u00e1visle na vn\u011bj\u0161\u00edch faktorech, je nezbytn\u00fd pro p\u0159esn\u00e9 hodnocen\u00ed \u00fa\u010dinnosti terapi\u00ed.<\/p>\n

2. n\u00ed finan\u010dn\u00edch prost\u0159edk\u016f<\/h3>\n

Navzdory sv\u00e9mu potenci\u00e1lu sn\u00ed\u017eit z\u00e1t\u011b\u017e zp\u016fsobenou v\u011bkem podm\u00edn\u011bn\u00fdmi chorobami je v\u00fdzkum dlouhov\u011bkosti ve srovn\u00e1n\u00ed s iniciativami zam\u011b\u0159en\u00fdmi na konkr\u00e9tn\u00ed choroby st\u00e1le nedostate\u010dn\u011b financov\u00e1n. P\u0159erozd\u011blen\u00ed finan\u010dn\u00edch prost\u0159edk\u016f na v\u00fdzkum mechanism\u016f st\u00e1rnut\u00ed by mohlo p\u0159in\u00e9st zna\u010dn\u00e9 p\u0159\u00ednosy pro zdrav\u00ed. Vyv\u00e1\u017een\u00fd pom\u011br mezi investicemi do v\u00fdzkumu zam\u011b\u0159en\u00e9ho na konkr\u00e9tn\u00ed nemoci a do v\u00fdzkumu p\u0159\u00ed\u010din st\u00e1rnut\u00ed je rozhoduj\u00edc\u00ed pro maximalizaci dlouhodob\u00fdch v\u00fdsledk\u016f v oblasti zdrav\u00ed.<\/p>\n

3. Vylep\u0161en\u00e9 v\u00fdzkumn\u00e9 modely<\/h3>\n

Pro \u00fa\u010dinn\u00e9 testov\u00e1n\u00ed anti-agingov\u00fdch procedur jsou zapot\u0159eb\u00ed p\u0159esn\u00e9 modely napodobuj\u00edc\u00ed proces st\u00e1rnut\u00ed u lid\u00ed. Sou\u010dasn\u00e9 modely, jako jsou pokusy na zv\u00ed\u0159atech a bun\u011b\u010dn\u00e9 kultury, mohou komplexnost st\u00e1rnut\u00ed u lid\u00ed zachytit pouze omezen\u011b. Aby bylo mo\u017en\u00e9 dos\u00e1hnout pokroku ve v\u00fdzkumu dlouhov\u011bkosti, je t\u0159eba vyvinout reprezentativn\u011bj\u0161\u00ed modely, kter\u00e9 l\u00e9pe zachycuj\u00ed lidskou fyziologii a nemoci spojen\u00e9 se st\u00e1rnut\u00edm.<\/p>\n

4.\u00a0P\u0159\u00edsn\u011bj\u0161\u00ed regula\u010dn\u00ed r\u00e1mec<\/h3>\n

Tradi\u010dn\u00ed p\u0159edpisy pro v\u00fdvoj l\u00e9\u010div jsou pro terapie dlouhov\u011bkosti, kter\u00e9 se zam\u011b\u0159uj\u00ed na n\u011bkolik nemoc\u00ed souvisej\u00edc\u00edch s v\u011bkem sou\u010dasn\u011b, m\u00e1lo vhodn\u00e9. Regula\u010dn\u00ed r\u00e1mec proto mus\u00ed b\u00fdt upraven tak, aby umo\u017e\u0148oval terapie, kter\u00e9 se nezam\u011b\u0159uj\u00ed na konkr\u00e9tn\u00ed nemoci, ale na st\u00e1rnut\u00ed jako takov\u00e9. To vy\u017eaduje p\u0159ehodnocen\u00ed metodik posuzov\u00e1n\u00ed rizik a etick\u00fdch \u00favah, aby se usnadnil v\u00fdvoj a testov\u00e1n\u00ed opat\u0159en\u00ed proti st\u00e1rnut\u00ed.<\/p>\n

5. Lep\u0161\u00ed porozum\u011bn\u00ed ve\u0159ejnosti<\/h3>\n

Navzdory rostouc\u00edmu medi\u00e1ln\u00edmu pokryt\u00ed st\u00e1le existuj\u00ed myln\u00e9 p\u0159edstavy o v\u00fdzkumu dlouhov\u011bkosti, kter\u00e9 negativn\u011b ovliv\u0148uj\u00ed podporu ve\u0159ejnosti. Je proto d\u016fle\u017eit\u00e9 informovat ve\u0159ejnost o potenci\u00e1ln\u00edch p\u0159\u00ednosech v\u00fdzkumu dlouhov\u011bkosti pro obecn\u00e9 zdrav\u00ed a blahobyt, aby bylo mo\u017en\u00e9 z\u00edskat \u0161ir\u0161\u00ed podporu a financov\u00e1n\u00ed.<\/p>\n

Zvy\u0161ov\u00e1n\u00ed pov\u011bdom\u00ed ve\u0159ejnosti, \u00faprava p\u0159edpis\u016f, zlep\u0161en\u00ed v\u00fdzkumn\u00fdch model\u016f, p\u0159erozd\u011blen\u00ed finan\u010dn\u00edch prost\u0159edk\u016f a optimalizace biomarker\u016f urychl\u00ed pokrok ve v\u00fdzkumu dlouhov\u011bkosti. Pokud se poda\u0159\u00ed tyto v\u00fdzvy p\u0159ekonat, m\u016f\u017ee se otev\u0159\u00edt cesta k budoucnosti, ve kter\u00e9 bude zdrav\u011bj\u0161\u00ed st\u00e1rnut\u00ed a vy\u0161\u0161\u00ed pr\u016fm\u011brn\u00e1 d\u00e9lka \u017eivota nejen c\u00edlem, ale i realitou.<\/p>\n

V\u00fdzvy zm\u00edn\u011bn\u00e9 v tomto \u010dl\u00e1nku nezahrnuj\u00ed v\u0161echny probl\u00e9my identifikovan\u00e9 konsorciem Bottlenecks Consortium. Dal\u0161\u00edmi \u010dasto zmi\u0148ovan\u00fdmi probl\u00e9my jsou nedostate\u010dn\u00e1 v\u00fdm\u011bna dat mezi v\u00fdzkumn\u00edky v oblasti dlouhov\u011bkosti ( ) a nedostatek kvalifikovan\u00fdch odborn\u00edk\u016f, kte\u0159\u00ed by se do t\u00e9to oblasti zapojili. Druh\u00fd zm\u00edn\u011bn\u00fd probl\u00e9m je \u010d\u00e1ste\u010dn\u011b spojen s v\u00fd\u0161e uveden\u00fdmi faktory, jako jsou finan\u010dn\u00ed p\u0159ek\u00e1\u017eky a regula\u010dn\u00ed p\u0159ek\u00e1\u017eky, kter\u00e9 mohou odradit za\u010d\u00ednaj\u00edc\u00ed v\u00fdzkumn\u00edky od zapojen\u00ed se do v\u00fdzkumu dlouhov\u011bkosti.<\/p>\n

Podrobn\u00e9 v\u00fdsledky pr\u016fzkumu a detailn\u00ed anal\u00fdzy s grafy a infografikami jsou k dispozici na webov\u00fdch str\u00e1nk\u00e1ch Longevity Biotech Fellowship<\/em><\/a>.<\/p>\n

Epigenetick\u00e9 zm\u011bny jsou p\u0159\u00ed\u010dinou st\u00e1rnut\u00ed<\/h2>\n

Studie ukazuje, \u017ee manipulac\u00ed s epigenomem lze st\u00e1rnut\u00ed urychlit i zvr\u00e1tit<\/strong><\/p>\n

Podle teorie o informaci st\u00e1rnut\u00ed je na\u0161e genom srovnateln\u00fd s biologick\u00fdm hardwarem, zat\u00edmco epigenom je software \u2013 a st\u00e1rnut\u00ed je probl\u00e9m softwaru, kter\u00fd lze vy\u0159e\u0161it restartov\u00e1n\u00edm ze z\u00e1lo\u017en\u00ed kopie.<\/p>\n

Mezin\u00e1rodn\u00ed studie, na kter\u00e9 se pracovalo 13 let, poprv\u00e9 ukazuje, \u017ee zhor\u0161en\u00ed zp\u016fsobu, jak\u00fdm je DNA organizov\u00e1na a regulov\u00e1na \u2013 zn\u00e1m\u00e9 jako epigenetika \u2013 m\u016f\u017ee urychlit st\u00e1rnut\u00ed organismu nez\u00e1visle na zm\u011bn\u00e1ch genetick\u00e9ho k\u00f3du samotn\u00e9ho.<\/p>\n

V\u011bdci vyvolali u my\u0161\u00ed zrychlen\u00e9 st\u00e1rnut\u00ed t\u00edm, \u017ee zp\u016fsobili zlomy v DNA, kter\u00e9 spustily proces bun\u011b\u010dn\u00e9 opravy a zm\u011bny v organizaci DNA, tj. epigenetick\u00e9 zm\u011bny. Auto\u0159i prok\u00e1zali, \u017ee my\u0161i st\u00e1rly rychleji v d\u016fsledku zv\u00fd\u0161en\u00e9 z\u00e1t\u011b\u017ee zp\u016fsoben\u00e9 reorganizac\u00ed DNA a v\u00fdsledn\u00e9 ztr\u00e1ty epigenetick\u00fdch informac\u00ed, a nikoli v d\u016fsledku zm\u011bn v sekvenci DNA.<\/p>\n

Pomoc\u00ed genov\u00e9 terapie pak do my\u0161\u00ed vnesli faktory, kter\u00e9 \u010d\u00e1ste\u010dn\u011b obnovily integritu epigenomu a uvedly org\u00e1ny a tk\u00e1n\u011b do mladistv\u00e9ho stavu, tak\u017ee st\u00e1rnut\u00ed \u201epostupovalo a ustupovalo podle libosti\u201c. <\/p>\n

\u201eV\u011b\u0159\u00edme, \u017ee na\u0161e studie je prvn\u00ed, kter\u00e1 ukazuje epigenetick\u00e9 zm\u011bny jako prim\u00e1rn\u00ed p\u0159\u00ed\u010dinu st\u00e1rnut\u00ed u savc\u016f,\u201c \u0159ekl hlavn\u00ed autor studie David Sinclair, profesor genetiky na Blavatnik Institute Harvard Medical School a spoludirektor Paul F. Glenn Center for Biology of Aging Research.<\/p>\n

Epigenetick\u00fd restart vedl ke zlep\u0161en\u00ed marker\u016f st\u00e1rnut\u00ed v ledvin\u00e1ch, svalech a o\u010d\u00edch. I kdy\u017e je tato studie velmi v\u00fdznamn\u00e1, jin\u00ed v\u011bdci v t\u00e9to oblasti varuj\u00ed, \u017ee bez dal\u0161\u00edch experiment\u016f je je\u0161t\u011b p\u0159\u00edli\u0161 brzy na to, aby bylo mo\u017en\u00e9 vyvodit z\u00e1sadn\u00ed z\u00e1v\u011bry o povaze st\u00e1rnut\u00ed a na\u0161\u00ed schopnosti jej zvr\u00e1tit.<\/p>\n

Leonard Guarente, americk\u00fd biolog, profesor biologie na Novartis a \u0159editel Paul F. Glenn Center for Biology of Aging Research na MIT (Massachusetts Institute of Technology) v Bostonu, k tomu \u0159\u00edk\u00e1:<\/p>\n

\u201eStudie kvasinkov\u00fdch a sav\u010d\u00edch bun\u011bk za posledn\u00edch 25 let uk\u00e1zaly, \u017ee zlomy dvojit\u00e9 \u0161roubovice DNA zp\u016fsobuj\u00ed redistribuci epigenetick\u00fdch regul\u00e1tor\u016f, kter\u00e9 ovliv\u0148uj\u00ed acetylaci a metylaci histon\u016f v cel\u00e9m genomu, co\u017e by mohlo b\u00fdt p\u0159\u00ed\u010dinou st\u00e1rnut\u00ed. Tato pr\u00e1ce popisuje, jak lze u mlad\u00fdch my\u0161\u00ed vyvolat mal\u00e9 mno\u017estv\u00ed genomov\u00fdch zlomenin DNA a jak lze pozorovat jejich \u00fa\u010dinky b\u011bhem st\u00e1rnut\u00ed. V\u00fdsledky skute\u010dn\u011b ukazuj\u00ed redistribuci epigenetick\u00fdch marker\u016f v cel\u00e9m genomu a zrychlen\u00e9 biologick\u00e9 st\u00e1rnut\u00ed m\u011b\u0159en\u00e9 epigenetick\u00fdmi hodinami metylace DNA, stejn\u011b jako kanonick\u00e9 fenotypy st\u00e1rnut\u00ed u zv\u00ed\u0159at. Tyto epigenetick\u00e9 zm\u011bny lze \u010d\u00e1ste\u010dn\u011b zvr\u00e1tit expres\u00ed Yamanaka faktor\u016f. V\u00fdsledky podporuj\u00ed model, ve kter\u00e9m jsou zlomy DNA a jimi vyvolan\u00e9 zm\u011bny v epigenetick\u00e9 krajin\u011b d\u016fle\u017eit\u00fdmi p\u0159\u00ed\u010dinami norm\u00e1ln\u00edho st\u00e1rnut\u00ed savc\u016f.<\/p>\n

Guarente je zn\u00e1m\u00fd p\u0159edev\u0161\u00edm sv\u00fdm v\u00fdzkumem prodlou\u017een\u00ed d\u00e9lky \u017eivota u kvasinek Saccharomyces cerevisiae, \u0161krkavek a my\u0161\u00ed.<\/p>\n

Reference<\/h3>\n

Yang, J. H., Hayano, M., Griffin, P. T., Amorim, J. A., Bonkowski, M. S., Apostolides, J. K., Salfati, E. L., Blanchette, M., Munding, E. M., Bhakta, M., Chew, Y. C., Guo, W., Yang, X., Maybury-Lewis, S., Tian, X., Ross, J. M., Coppotelli, G., Meer, M. V., Rogers-Hammond, R., . . . Sinclair, D. A. (2023). Loss of epigenetic information as a cause of mammalian aging. Cell<\/em>, 186<\/em>(2), 305-326.e27. https:\/\/doi.org\/10.1016\/j.cell.2022.12.027<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

Touha prodlou\u017eit lidsk\u00fd \u017eivot a podpo\u0159it zdrav\u011bj\u0161\u00ed st\u00e1rnut\u00ed se vyvinula ze sci-fi sc\u00e9n\u00e1\u0159e do hmatateln\u00e9ho v\u011bdeck\u00e9ho c\u00edle. V posledn\u00edch letech pokroky ve v\u00fdzkumu dlouhov\u011bkosti podn\u00edtily optimismus, \u017ee st\u00e1rnut\u00ed lze v pr\u016fb\u011bhu na\u0161eho \u017eivota \u00fa\u010dinn\u011b bojovat.<\/p>\n","protected":false},"author":1,"featured_media":25981296,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[150],"tags":[],"class_list":["post-25981297","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-proti-starnuti"],"_links":{"self":[{"href":"https:\/\/nutagen.com\/cs\/wp-json\/wp\/v2\/posts\/25981297","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nutagen.com\/cs\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/nutagen.com\/cs\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/nutagen.com\/cs\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/nutagen.com\/cs\/wp-json\/wp\/v2\/comments?post=25981297"}],"version-history":[{"count":0,"href":"https:\/\/nutagen.com\/cs\/wp-json\/wp\/v2\/posts\/25981297\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/nutagen.com\/cs\/wp-json\/wp\/v2\/media\/25981296"}],"wp:attachment":[{"href":"https:\/\/nutagen.com\/cs\/wp-json\/wp\/v2\/media?parent=25981297"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/nutagen.com\/cs\/wp-json\/wp\/v2\/categories?post=25981297"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/nutagen.com\/cs\/wp-json\/wp\/v2\/tags?post=25981297"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}